Adolescent Stress and Substance Intervention Subsequent to Trauma

NCT07197476 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2026-04-28

No results posted yet for this study

Summary

The long-term goal of this study is to address the adoption of the new trauma center requirement to establish best practices of screening for acute stress with an intervention to prevent both adolescent PTSD and substance use. The investigators will develop, refine, and pilot test the Adolescent Stress and Substance Intervention Subsequent to Trauma (ASSIST) video interventions that build upon the American College of Surgeons Committee on Trauma guidelines to improve mental health care during and after hospitalization for traumatic injury. The aims are:

PHASE I - Primary Aim 1: To develop and refine two ASSIST video interventions for adolescents and parents admitted to a level 1 pediatric trauma center.

PHASE II

* Primary Aim 2a: To evaluate the feasibility, acceptability and implementation potential of the ASSIST video interventions.
* Primary Aim 2b: Develop the ASSIST implementation protocol using a national advisory panel of pediatric trauma center leaders.

Participants in PHASE 1:

Parent and child duo:

* Review storyboards for the video interventions
* Participate in qualitative interviews at hospital admission and 1 month following discharge

Pediatric trauma center clinical staff members:

\- Complete qualitative interviews

Participants in PHASE II:

Parent and child duo:

* Shown their own video interventions
* Complete assessments at admission and 1-, 2-, 3- months after discharge

Conditions

  • PTSD
  • Substance Use Disorder (SUD)
  • Acute Stress Disorder

Interventions

BEHAVIORAL

ASSIST Video Intervention

Video intervention for participants: adolescent trauma patient-parent dyads.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH
  • Rhode Island Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-03
Primary Completion
2027-04-30
Completion
2027-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07197476 on ClinicalTrials.gov